Aisling Capital as of Sept. 30, 2014
Portfolio Holdings for Aisling Capital
Aisling Capital holds 13 positions in its portfolio as reported in the September 2014 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Versartis | 16.0 | $55M | 2.0M | 28.04 | |
Transenterix | 12.2 | $42M | 8.3M | 5.04 | |
Zeltiq Aesthetics | 11.6 | $40M | 2.6M | 15.19 | |
Cempra | 10.4 | $36M | 3.3M | 10.73 | |
Durata Therapeutics | 10.0 | $35M | 2.0M | 17.03 | |
Chimerix (CMRX) | 9.7 | $33M | 1.5M | 21.94 | |
Esperion Therapeutics (ESPR) | 9.4 | $33M | 2.1M | 15.84 | |
Agile Therapeutics | 5.5 | $19M | 2.2M | 8.72 | |
Pernix Therapeutics Holdings | 5.3 | $18M | 2.0M | 8.98 | |
Sorrento Therapeutics (SRNE) | 3.5 | $12M | 1.8M | 6.75 | |
Ambit Bioscience | 3.3 | $11M | 1.7M | 6.91 | |
Lombard Med (EVARF) | 1.9 | $6.4M | 886k | 7.20 | |
Mei Pharma | 1.4 | $4.9M | 770k | 6.34 |